Knowledge of Human Papillomavirus: Differences by Self-Reported Treatment for Genital Warts and Sociodemographic Characteristics

By Koshiol Jill   Rutten Lila Finney   Moser Richard   Hesse Nicola  

Journal of Health Communication, Vol. 14, Iss. 4, 2009-06 ,pp. : 331-345

Taylor & Francis Ltd

Access to resources Recommend Favorite

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

By de Jong A.   O'Neill T.   Khan A.Y.   Kwappenberg K.M.C.   Chisholm S.E.   Whittle N.R.   Dobson J.A.   Jack L.C.   St Clair Roberts J.   Offringa R.   van der Burg S.H.   Hickling J.K.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3456-3464

Elsevier

Access to resources Recommend Favorite

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer

By Boursnell M.E.G.   Rutherford E.   Hickling J.K.   Rollinson E.A.   Munro A.J.   Rolley N.   McLean C.S.   Borysiewicz L.K.   Vousden K.   Inglis S.C.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1485-1494

Elsevier

Access to resources Recommend Favorite

N95-Companion Measurement of C_out/C_in Ratios for Two N95 Filtering Facepiece Respirators and One Surgical Mask

By Rengasamy Samy   Eimer Benjamin C.  

Journal of Occupational and Environmental Hygiene, Vol. 10, Iss. 10, 2013-10 ,pp. : 527-532

Taylor & Francis Ltd

Access to resources Recommend Favorite

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A

By Thompson H.S.G.   Davies M.L.   Watts M.J.   Mann A.E.   Holding F.P.   O'Neill T.   Beech J.T.   Thompson S.J.   Leesman G.D.   Ulrich J.T.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1993-1999

Elsevier

Access to resources Recommend Favorite